Nordson Corporation Earnings Recaps
Nordson's shares gained 3.8% post-earnings, driven by record sales and earnings that modestly outpaced expectations, supported by strong organic growth, improved operating leverage, and sustained margin performance.
Key takeaways
- Quarterly sales hit a record $741 million, up 8% year-over-year, including 7% organic growth across all three segments.
- EBITDA reached a second quarter record of $235 million, with a stable 32% margin, reflecting disciplined cost management despite incremental EBITDA contribution on the low end of the usual range.
- Adjusted EPS grew 18% to a new Q2 record of $2.86, slightly above guidance midpoint, benefiting from operational leverage and lower tax rate expectations (now 18–19%).
- Free cash flow totaled $170 million, converting over 100% of net income, supporting a balanced use of capital for share repurchases, dividends, and strategic acquisitions (notably the CapstanAG precision agriculture bolt-on).
- One-time pension settlement charges ($24 million pretax) and other noncash items impacted GAAP net income but were excluded from adjusted results; net interest expense declined due to lower debt and stable rates.
Nordson Corporation reported a strong first quarter of fiscal 2026, with record sales of $669 million, marking a 9% increase year-over-year, driven by robust organic growth and significant strength in the semiconductor market.
Key takeaways
- Achieved record sales of $669 million, with 7% organic growth driven by demand in Asia and particularly strong performance in the ATS segment.
- EBITDA increased by 8% to a first-quarter record of $203 million, maintaining EBITDA margins at 30%.
- Adjusted EPS of $2.37 marked a 15% year-over-year increase, surpassing guidance by $0.02.
- Free cash flow reached $123 million, enabling strategic share repurchases, dividends, and ongoing investments.
- Maintained a robust balance sheet with net interest expense down by $3 million due to reduced debt levels.
Nordson Corporation delivered solid Q4 and full-year results for fiscal 2025, with record sales, adjusted earnings growth, and strong cash flow generation, reflecting the successful execution of its Ascend Strategy.
Key takeaways
- Q4 sales rose 1% YoY to $752 million, with adjusted EPS up 9% to $3.03, exceeding guidance.
- Record EBITDA of $256 million and an EBITDA margin of 34% demonstrate strong operational efficiency amid market challenges.
- Free cash flow conversion reached 136% of net income, supporting $300 million in share repurchases and dividend increases for the 62nd consecutive year.
- The divestiture of the medical contract manufacturing business improved margins and enhanced focus on strategic medical segments.
Nordson Corporation reported strong fiscal Q3 2025 results, with sales reaching $742 million, exceeding guidance and reflecting robust contributions from both organic growth and the recent Atrion acquisition. Adjusted EPS grew 13% year-over-year, driven by efficient operational performance.
Key takeaways
- Sales increased 12% year-over-year, with organic sales up 2% and a significant 8% contribution from the Atrion acquisition.
- Record free cash flow of $226 million, achieving a conversion rate of 180% of net income, enabling debt reduction and shareholder returns.
- Adjusted earnings per share rose 13% to $2.73, surpassing guidance by $0.08, highlighting effective cost management and integration execution.